UROGEN PHARMA LTD (URGN) Stock Price, Quote, News and Overview

What is the stock price of UROGEN PHARMA LTD today?

The current stock price of URGN is 9.69 USD. The price decreased by -11.51% in the last trading session.

What is the ticker symbol for UROGEN PHARMA LTD stock?

The exchange symbol of UROGEN PHARMA LTD is URGN and it is listed on the Nasdaq exchange.

On which exchange is URGN stock listed?

URGN stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for UROGEN PHARMA LTD stock?

14 analysts have analysed URGN and the average price target is 34.68 USD. This implies a price increase of 257.89% is expected in the next year compared to the current price of 9.69. Check the UROGEN PHARMA LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is UROGEN PHARMA LTD worth?

UROGEN PHARMA LTD (URGN) has a market capitalization of 446.61M USD. This makes URGN a Small Cap stock.

How many employees does UROGEN PHARMA LTD have?

UROGEN PHARMA LTD (URGN) currently has 235 employees.

What are the support and resistance levels for UROGEN PHARMA LTD (URGN) stock?

UROGEN PHARMA LTD (URGN) has a support level at 9.45 and a resistance level at 10.39. Check the full technical report for a detailed analysis of URGN support and resistance levels.

Is UROGEN PHARMA LTD (URGN) expected to grow?

The Revenue of UROGEN PHARMA LTD (URGN) is expected to grow by 33.25% in the next year. Check the estimates tab for more information on the URGN EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy UROGEN PHARMA LTD (URGN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of URGN, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of URGN, evaluating the profitability, health, valuation and growth aspects
• UROGEN PHARMA LTD (URGN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• UROGEN PHARMA LTD (URGN) Sales and EPS estimates to see what analysts future expectations are.
• UROGEN PHARMA LTD (URGN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• UROGEN PHARMA LTD (URGN) Insider and Institutional Ownership to learn about the owners and their transactions.
• UROGEN PHARMA LTD (URGN) Stock Chart to make your own analysis
• UROGEN PHARMA LTD (URGN) Latest news and press-releases to stay up to date.

Does UROGEN PHARMA LTD (URGN) stock pay dividends?

URGN does not pay a dividend.

When does UROGEN PHARMA LTD (URGN) report earnings?

UROGEN PHARMA LTD (URGN) will report earnings on 2025-05-08, before the market open.

What is the Price/Earnings (PE) ratio of UROGEN PHARMA LTD (URGN)?

UROGEN PHARMA LTD (URGN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.23).

What is the Short Interest ratio of UROGEN PHARMA LTD (URGN) stock?

The outstanding short interest for UROGEN PHARMA LTD (URGN) is 12.13% of its float. Check the ownership tab for more information on the URGN short interest.

ChartMill assigns a fundamental rating of 3 / 10 to URGN. URGN has a bad profitability rating. Also its financial health evaluation is rather negative.

Over the last trailing twelve months URGN reported a non-GAAP Earnings per Share(EPS) of -3.23. The EPS increased by 13.4% compared to the year before.

ChartMill assigns a Buy % Consensus number of 84% to URGN. The Buy consensus is the average rating of analysts ratings from 14 analysts.

For the next year, analysts expect an EPS growth of 8.2% and a revenue growth 33.25% for URGN